First-Trimester Preterm Preeclampsia Screening in Nulliparous Women: The Great Obstetrical Syndrome (GOS) Study.


Journal

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
ISSN: 1701-2163
Titre abrégé: J Obstet Gynaecol Can
Pays: Netherlands
ID NLM: 101126664

Informations de publication

Date de publication:
01 2021
Historique:
received: 20 03 2020
revised: 03 06 2020
accepted: 04 06 2020
pubmed: 13 9 2020
medline: 1 7 2021
entrez: 12 9 2020
Statut: ppublish

Résumé

To estimate the ability of a combination of first-trimester markers to predict preterm preeclampsia in nulliparous women. We conducted a prospective cohort study of nulliparous women with singleton gestations, recruited between 11 Among 4659 nulliparous women with singleton gestations, our final model included 4 variables: MAP MoM, log The combination of MAP, maternal serum PlGF and AFP, and UtA-PI are useful to identify nulliparous women at high risk of preterm preeclampsia but also at high risk of other great obstetrical syndromes.

Identifiants

pubmed: 32917539
pii: S1701-2163(20)30527-2
doi: 10.1016/j.jogc.2020.06.011
pii:
doi:

Substances chimiques

Biomarkers 0
Placenta Growth Factor 144589-93-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-49

Informations de copyright

Copyright © 2020 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.

Auteurs

Amélie Boutin (A)

Reproduction, Mother and Child Health Unit, CHU de Québec-Université Laval Research Center, Québec City, QC.

Cédric Gasse (C)

Reproduction, Mother and Child Health Unit, CHU de Québec-Université Laval Research Center, Québec City, QC; Department of Social and Preventive Medicine, Université Laval, Québec City, QC.

Paul Guerby (P)

Reproduction, Mother and Child Health Unit, CHU de Québec-Université Laval Research Center, Québec City, QC; Department of Obstetrics, Gynecology, and Reproduction, Université Laval, Québec City, QC.

Yves Giguère (Y)

Reproduction, Mother and Child Health Unit, CHU de Québec-Université Laval Research Center, Québec City, QC; Department of Molecular Biology, Medical Biochemistry, and Pathology, Université Laval, Québec City, QC.

Amélie Tétu (A)

Reproduction, Mother and Child Health Unit, CHU de Québec-Université Laval Research Center, Québec City, QC.

Emmanuel Bujold (E)

Reproduction, Mother and Child Health Unit, CHU de Québec-Université Laval Research Center, Québec City, QC; Department of Obstetrics, Gynecology, and Reproduction, Université Laval, Québec City, QC. Electronic address: emmanuel.bujold@crchudequebec.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH